Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A revision/version label on the page footer was updated from v3.5.2 to v3.5.3, reflecting a technical software release rather than a change to the represented clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T18:46:53.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:39:54.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Added Mucosa-associated lymphoma and B-cell chronic lymphocytic leukemia to the list of diseases relevant to the study.
    Difference
    0.1%
    Check dated 2026-03-28T03:26:17.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T01:01:58.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. No visible changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-03-06T18:16:49.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible changes to study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-02-13T13:32:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.